Ratings for RxSight (NASDAQ:RXST) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 6 | 2 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 3 | 2 | 0 | 0 | 0 |
| 3M Ago | 1 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for RxSight, presenting an average target of $64.12, a high estimate of $73.00, and a low estimate of $54.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 7.07%.
Interpreting Analyst Ratings: A Closer Look
The perception of RxSight...
Login or create a forever free account to read this news
Sign up/Log in